Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Free Cash FlowLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Solid Biosciences (SLDB) Other financing activities (2017 - 2024)

Solid Biosciences' Other financing activities history spans 4 years, with the latest figure at $286000.0 for Q2 2024.

  • For Q2 2024, Other financing activities changed N/A year-over-year to $286000.0; the TTM value through Dec 2024 reached $5.1 million, up 1680.84%, while the annual FY2024 figure was $5.1 million, N/A changed from the prior year.
  • Other financing activities for Q2 2024 was $286000.0 at Solid Biosciences, down from $4.8 million in the prior quarter.
  • Across five years, Other financing activities topped out at $4.8 million in Q1 2024 and bottomed at $286000.0 in Q2 2024.